Clinical trial

The Effect of Ixazomib on the Latent HIV Reservoir

NCT02946047

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Ixazomib 1 MG Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Ixazomib 2 MG Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Ixazomib 3 MG Normalized identity: ixazomib 3 MGView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Ixazomib 4 MG Normalized identity: ixazomib 4 MGView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

The Effect of Ixazomib on the Latent HIV Reservoir

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1, PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-03-20

PhasePHASE1 / PHASE2

Conditions

Human Immunodeficiency Virus (HIV)unresolved

Interventions

Ixazomib 1 MGDRUG

Ixazomib 2 MGDRUG

Ixazomib 3 MGDRUG · verified · RxNorm: ixazomib 3 MG

Ixazomib 4 MGDRUG · verified · RxNorm: ixazomib 4 MG

Sponsors & collaborators

Mayo Cliniclead sponsor

Takedacollaborator

Mapped research locations

RochesterMinnesota, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02946047 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.